Stifel analysts increased their price target on New Fortress Energy shares (NASDAQ:NFE) to $23.00, up from the previous $17.00, while reiterating a Buy rating on the stock. According to InvestingPro ...

Stifel has initiated coverage of Cytokinetics (CYTK) with a buy rating, citing its drug aficamten, valuation and upcoming ...

Stifel raised the firm’s price target on Badger Infrastructure (BADFF) to C$53 from C$51 and keeps a Buy rating on the shares. Published first on ...

Edgewise Therapeutics (EWTX) stock traded flat as Stifel launched its coverage with a Hold recommendation, indicating a ...

Stifel raised the firm’s price target on Old Dominion (ODFL) to $193 from $176 and keeps a Hold rating on the shares. 2024 largely proved to be ...

Stifel raised the firm’s price target on Werner (WERN) to $35 from $30 and keeps a Hold rating on the shares. 2024 largely proved to be “the ...

Stifel analyst Brian Brophy raised the firm’s price target on Quanta Services (PWR) to $388 from $374 and keeps a Buy rating ...

On Wednesday, Vince Holding Corp (VNCE) stock saw a decline, ending the day at $2.35 which represents a decrease of $-0.60 or -20.34% from the prior close of $2.95. The stock opened at $2.95 and ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Cytokinetics receives a Buy rating from Stifel, with a promising outlook for aficamten in the $3 billion U.S. oHCM market, ...

Stifel initiated coverage of FanDuel parent company Flutter Thursday with a $320 target price and a buy rating.